Results 101 to 110 of about 289,325 (184)

Mexiletine dosing and tolerability in refractory chronic migraine: Insights from post-lidocaine infusion treatment

Cephalalgia Reports
Background Mexiletine is used as a preventive medication for refractory chronic migraine (rCM) and to prolong migraine improvement following intravenous lidocaine infusion. However, published evidence supporting its use in migraine remains limited.
Lucia Liao, Hsiangkuo Yuan, Dylan Selbst, Emily Casaletto, Jiangang Liao, Clinton G. Lauritsen   +5 more
doaj   +1 more source

Clopidogrel can be an effective complementary prophylactic for drug-refractory migraine with patent foramen ovale. [PDF]

J Investig Med, 2020
Guo Y, Shi Y, Zhu D, Liu R, Qi Y, Luo G.
europepmc   +1 more source

Resolution of Refractory Status Epilepticus With Ketamine Without Intubation in a Patient With Stroke-Like Migraine Attacks After Radiation Therapy (SMART) Syndrome

Case Reports in Neurological Medicine
Stroke-like migraine attacks after radiation therapy (SMART) syndrome is an infrequently reported complication arising years after radiation therapy that manifests as a reversible syndrome marked by migraine-like headaches, focal neurologic signs, and/or
Kyle N. Kaneko, Pablo Read, John M. Eaton, Yoshie Umemura, Justin L. Hoskin   +4 more
doaj   +1 more source

Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations. [PDF]

J Pain Res, 2020
Shafqat R, Flores-Montanez Y, Delbono V, Nahas SJ.   +3 more
europepmc   +1 more source

Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice

Journal of Pain Research, 2018
Jessica C Oswald, Nathaniel M Schuster UCSD Center for Pain Medicine, La Jolla, CA, USA Abstract: Now that the vascular hypothesis of migraine is no longer the prevailing theory of migraine pathogenesis, there is interest in developing acute migraine ...
Oswald JC, Schuster NM
doaj  

OC-09 | Atogepant in treatment-refractory chronic migraine: is a revision of current criteria for refractory migraine appropriate?

Confinia Cephalalgica
Background: Despite the emergence of novel targeted therapies, refractory migraine remains a major clinical challenge. According to the 2020 European Headache Federation (EHF) Consensus, patients experiencing ≥8 debilitating headache days per month are classified as "resistant" if they have failed at least three classes of preventive treatments, and as
openaire   +1 more source

Cannabidiol in the treatment of migraine: studies and future perspectives

Headache Medicine
Introduction: Migraine is one of the most disabling and prevalent conditions in the population. Is related to the release of pro-inflammatory mediators in the central nervous system, triggering painful episodes.
Taianara Sampaio Reis, Raimundo Feitosa Neto, Alana Maria Caland de Holanda Lustosa, Amauri Pereira da Silva Filho, Gabriel Cipriano Feitosa Oliveira, Isis Maria Lima Cruz, Támara Larissa Silva Barbosa, Marcus Vinícius Costa Fernandes   +7 more
doaj   +2 more sources

Pharmacological mechanisms underlying neurovascular alterations related to resistant and refractory migraine: CGRP pathways and beyond. [PDF]

J Headache Pain
Scuteri D, Kodounis M, Katsuki M, Bezgal B, Bednarczyk N, Alevetsovitis SK, Wołos J, Henriques M, Pinheiro TA, MaassenVanDenBrink A, Lampl C, School of Advanced Studies of the European Headache Federation (EHF-SAS).   +11 more
europepmc   +1 more source

Resolution of chronic refractory migraine and development of burning mouth syndrome after focused ultrasound thalamotomy: illustrative case. [PDF]

J Neurosurg Case Lessons
Shemesh SZ, Kelmer P, Fay-Karmon T, Hassin-Baer S, Ungar L.   +4 more
europepmc   +1 more source

Enhancing evidence for surgical treatment of refractory migraine suggestions on literature and study design. [PDF]

Int J Surg
Lu Z, Wang M, Wang Y.
europepmc   +1 more source